Here, we measured the percentage of NK cells (defined as CD45+ CD3- HLA-DR-/lo CD8+) in both the blood and bronchoalveolar lavage fluid (BAL) at baseline, and days 6-, 14-, and 21-post infection (Fig 3D and 3E). This evidence concerns the gene CD8A and infection.